That's the interpretation from Tim Anderson, a securities analyst at Sanford Bernstein, who notes that the drugmaker hasn't crowed about receiving a 6-month priority review, even though last Friday
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Taurel, who's about to retire as Eli Lilly's CEO, called Franklin his role model, an "instigator" who "helped set things in motion and continued to offer ideas and moral support, even as others
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The Japanese pharmaceutical company DAIICHI SANKYO Group has purchased the European rights to the osteoporosis medication EVISTA® from the U.S. Company Eli Lilly and Company. In the process, the comp
read more » Discuss Add this link to...Bury Add to:
| Bookmarks